Alterations of the p16-pRb Pathway and the Chromosome Locus 9p21–22 in Non-Small-Cell Lung Carcinomas
- 1 December 1998
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 153 (6) , 1749-1765
- https://doi.org/10.1016/s0002-9440(10)65690-8
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- A MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY OF THE MDM2 PROTEIN ISOFORMS ANDp53 GENE PRODUCT IN BRONCHOGENIC CARCINOMAThe Journal of Pathology, 1996
- Loss of heterozygosity at 9p21 loci and mutations of the MTS1 and MTS2 genes in human lung cancersInternational Journal of Cancer, 1995
- Alterations of CDKN2 (p16) in non‐small cell lung cancerGenes, Chromosomes and Cancer, 1995
- Altered Patterns of MDM2 and TP53 Expression in Human Bladder CancerJNCI Journal of the National Cancer Institute, 1994
- P16 gene in uncultured tumoursNature, 1994
- Colon cancer and DNA repair: have mismatches met their match?Trends in Genetics, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Biology of lung cancerCurrent Opinion in Oncology, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993